GNW
Genworth Financial IncPrice & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| CareScout matches | 1,486 | Q1 2026 | — |
| Holding company cash and liquid assets | $166M | Q1 2026 | — |
| PMIERs sufficiency ratio | 162% | Q1 2026 | — |
|
|
|||
| Primary new insurance written | $12,786M | Q1 2026 | — |
|
|
|||
| adjusted operating income (Enact) non-GAAP | $140M | Q1 2026 call | — |
|
|
|||
| adjusted operating income excluding the closed block non-GAAP | $109M | Q1 2026 call | — |
| average share repurchase price | $6.38 | as of April 30, 2026 call | — |
| capital returns received from Enact | $99M | Q1 2026 call | — |
| CareScout matches facilitated | 1,500 | Q1 2026 call | — |
| cash and liquid assets (holding company) | $166M | Q1 2026 call | — |
| CQN home care coverage of U.S. population aged 65+ | 97% | Q1 2026 call | — |
| ownership stake in Enact | 81% | Q1 2026 call | — |
| total share repurchases since initial authorization | $875M | as of April 30, 2026 call | — |
| Adjusted operating income non-GAAP | $144M | FY2025 | — |
| Adjusted operating income (loss) non-GAAP | $8M | Q4 2025 | — |
| Capital returns to Genworth from Enact | $127M | Q4 2025 | — |
| Care Assurance states live | 39 | as of December 31, 2025 | — |
| CareScout Quality Network matches with home care providers | 925 | Q4 2025 | — |
| Genworth holding company cash and liquid assets | $234M | Q4 2025 | — |
| LTC MYRAP estimated net present value achieved since 2012 from IFAs | $34.5B | since 2012 | — |
| LTC MYRAP gross incremental premium approvals | $100M | Q4 2025 | — |
| Share repurchases | $245M | FY2025 | — |
| Share repurchases since program inception | $790M | since program inception as of December 31, 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GNW
this stock
Genworth Financial Inc
|
$3.83B | +7.9% | +0.1% | 18.9 | 2.0% |
|
CILJF
China Life Insurance Co Ltd
|
$98.93B | +3.5% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$72.24B | +19.9% | — | — | 0.4% |
|
AFL
Aflac Inc
|
$62.62B | +10.3% | -9.3% | 14.1 | 2.5% |
|
MET
Metlife Inc
|
$60.11B | +17.6% | +8.6% | 18.1 | 2.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GNW | +5.9% | +9.9% | +18.4% | +2.9% | +7.9% |
| SPY | +1.3% | -0.2% | +10.1% | +1.1% | +10.7% |
| vs SPY | +4.6% | +10.1% | +8.2% | +1.8% | -2.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.